[Antisynthetase myopathy]
- PMID: 32101845
- DOI: 10.5692/clinicalneurol.cn-001383
[Antisynthetase myopathy]
Abstract
Inflammatory myopathies are a heterogeneous group of immune-mediated diseases that involve skeletal muscle as well as many other organs. The classification of inflammatory myopathies has been based on clinical diagnoses, pathological diagnoses, and autoantibodies, independently. Antisynthetase syndrome, characterized by myositis, interstitial lung disease, skin rash, arthropathy, and Raynaud phenomenon, is a clinical entity based on the presence of aminoacyl transfer RNA synthetase (ARS) antibodies in patients' serum. A cohort study of muscle biopsy entitled "Integrated Diagnosis Project for Inflammatory Myopathies" revealed that of 460 patients with idiopathic inflammatory myopathies, 51 (11%; female:male, 31:20) had antisynthetase myopathy. It is noted that anti-OJ antibodies, one of anti-ARS antibody subtypes, are clearly detected by RNA immunoprecipitation, but not conventional detection methods including line blot and enzyme-linked immunosorbent assays. The combined mean onset age of the patients was 60 years (range 13-85 years). There were no significant HLA-DRB1 alleles associated with anti-ARS antibodies. All patients with antisynthetase myopathy patients presented muscle limb weakness; 14 had severe weakness, 17 neck weakness, 15 dysphagia, and 15 muscle atrophy. Although patients with anti-OJ antibodies showed severe muscle weakness, the clinical presentations defined by anti-ARS antibodies were relatively homogeneous. In muscle pathology, perifascicular necrosis is a distinctive hallmark of antisynthetase myopathy. Patients with antisynthetase myopathy responded to the combination of immunosuppressive therapy, with favorable outcomes. However, interstitial lung disease, found in 41 patients, was more closely related to mortality than myositis. Antisynthetase myopathy has a distinct clinical and histological entity among idiopathic inflammatory myopathies.
Keywords: aminoacyl transfer RNA synthetase (ARS); anti-OJ antibodies; autoantibodies; inflammatory myopathies; muscle pathology.
Similar articles
-
Skeletal Muscle Involvement in Antisynthetase Syndrome.JAMA Neurol. 2017 Aug 1;74(8):992-999. doi: 10.1001/jamaneurol.2017.0934. JAMA Neurol. 2017. PMID: 28586844 Free PMC article.
-
Integrated Diagnosis Project for Inflammatory Myopathies: An association between autoantibodies and muscle pathology.Autoimmun Rev. 2017 Jul;16(7):693-700. doi: 10.1016/j.autrev.2017.05.003. Epub 2017 May 4. Autoimmun Rev. 2017. PMID: 28479486 Review.
-
[Clinical and radiological features of adult patients with different antisynthetase syndrome based on serum anti-aminoacyl-tRNA synthetase antibody type].Zhonghua Jie He He Hu Xi Za Zhi. 2017 Dec 12;40(12):919-924. doi: 10.3760/cma.j.issn.1001-0939.2017.12.011. Zhonghua Jie He He Hu Xi Za Zhi. 2017. PMID: 29224302 Chinese.
-
Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies.Autoimmunity. 2006 May;39(3):233-41. doi: 10.1080/08916930600622884. Autoimmunity. 2006. PMID: 16769657
-
Myositis-related interstitial lung disease and antisynthetase syndrome.J Bras Pneumol. 2011 Jan-Feb;37(1):100-9. doi: 10.1590/s1806-37132011000100015. J Bras Pneumol. 2011. PMID: 21390438 Free PMC article. Review.
Cited by
-
Anti-OJ Antibody-positive Antisynthetase Myopathy Diagnosed after Pulmonary Embolization.Intern Med. 2025 Jun 1;64(11):1750-1755. doi: 10.2169/internalmedicine.4201-24. Epub 2024 Nov 8. Intern Med. 2025. PMID: 39523002 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials